JCML

Clinical trials for JCML explained in plain language.

Never miss a new study

Get alerted when new JCML trials appear

Sign up with your email to follow new studies for JCML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with rare leukemia: drug combo trial launches

Disease control Recruiting now

This study tests two drugs, trametinib and azacitidine, with or without chemotherapy, in children and young adults newly diagnosed with juvenile myelomonocytic leukemia (JMML), a rare blood cancer. Lower-risk patients get the two-drug combo; higher-risk patients also get two addi…

Matched conditions: JCML

Phase: PHASE1, PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control

Last updated May 13, 2026 16:03 UTC

JCML

Get alerted when new JCML trials appear

New hope for kids with rare leukemia: drug combo trial launches